(19)
(11) EP 1 874 734 A1

(12)

(43) Date of publication:
09.01.2008 Bulletin 2008/02

(21) Application number: 06708303.0

(22) Date of filing: 16.02.2006
(51) International Patent Classification (IPC): 
C07D 233/90(2006.01)
C07D 403/12(2006.01)
C07D 401/06(2006.01)
C07D 405/04(2006.01)
C07D 405/12(2006.01)
C07D 405/06(2006.01)
C07D 401/12(2006.01)
A61K 31/4164(2006.01)
A61P 37/00(2006.01)
A61P 29/00(2006.01)
C07D 417/04(2006.01)
(86) International application number:
PCT/EP2006/060009
(87) International publication number:
WO 2006/087355 (24.08.2006 Gazette 2006/34)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR

(30) Priority: 16.02.2005 EP 05101171
16.02.2005 US 653091 P

(71) Applicant: Solvay Pharmaceuticals B.V.
1381 CP Weesp (NL)

(72) Inventors:
  • LANGE, Josephus, H. M. c/o IPSI Department
    NL-1381 CP Weesp (NL)
  • STUIVENBERG, Herman H. c/o IPSI Department
    NL-1381 CP Weesp (NL)
  • VAN VLIET, Bernard J. c/o IPSI Department
    NL-1381 CP Weesp (NL)

(74) Representative: Verhage, Marinus et al
Octrooibureau Zoan B.V., P.O. Box 140
1380 CP Weesp
1380 CP Weesp (NL)

   


(54) 1H-IMIDIAZOLE DERIVATIVES AS CANNABINOID CB2 RECEPTOR MODULATORS